Biogaia AB
STO:BIOG B

Watchlist Manager
Biogaia AB Logo
Biogaia AB
STO:BIOG B
Watchlist
Price: 110.2 SEK 0.64% Market Closed
Market Cap: 11.1B SEK
Have any thoughts about
Biogaia AB?
Write Note

Biogaia AB
Other Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Biogaia AB
Other Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Biogaia AB
STO:BIOG B
Other Current Liabilities
kr51.3m
CAGR 3-Years
19%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
Bonesupport Holding AB
STO:BONEX
Other Current Liabilities
kr91.1m
CAGR 3-Years
42%
CAGR 5-Years
16%
CAGR 10-Years
N/A
Vitrolife AB
STO:VITR
Other Current Liabilities
kr192m
CAGR 3-Years
48%
CAGR 5-Years
27%
CAGR 10-Years
9%
Probi AB
STO:PROB
Other Current Liabilities
kr35.4m
CAGR 3-Years
8%
CAGR 5-Years
-5%
CAGR 10-Years
5%
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Other Current Liabilities
kr6.4B
CAGR 3-Years
9%
CAGR 5-Years
11%
CAGR 10-Years
24%
BioArctic AB
STO:BIOA B
Other Current Liabilities
kr49.3m
CAGR 3-Years
-17%
CAGR 5-Years
-32%
CAGR 10-Years
N/A
No Stocks Found

Biogaia AB
Glance View

Market Cap
11.1B SEK
Industry
Biotechnology

BioGaia AB engages in the development, marketing, and sale of probiotic products. The company is headquartered in Stockholm, Stockholm. The firm develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics segment drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products; The Adult Health segment (gut health tablets, oral health lozenges and cultures as an ingredient in a licensee’s dairy products) and the Other (royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc.). The firm operates worldwide.

BIOG B Intrinsic Value
112.88 SEK
Undervaluation 2%
Intrinsic Value
Price

See Also

What is Biogaia AB's Other Current Liabilities?
Other Current Liabilities
51.3m SEK

Based on the financial report for Dec 31, 2023, Biogaia AB's Other Current Liabilities amounts to 51.3m SEK.

What is Biogaia AB's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 5Y
-1%

Over the last year, the Other Current Liabilities growth was 17%. The average annual Other Current Liabilities growth rates for Biogaia AB have been 19% over the past three years , -1% over the past five years .

Back to Top